UPDATE 1-U.S. FDA approves Lundbeck's migraine prevention therapyReuters: Company News • about 4 years ago---
- "(Adds details on approval) By Manas Mishra and Mrinalika Roy Feb 21 (Reuters) -
The U.S. Food and Drug Administration approved Lundbeck A/S' migraine prevention
therapy, which the Danish drugmaker acquired through its near $2 billion deal for
Alder BioPharmaceuticals in 2019, the company said on Friday."